Sapporo Clinical Laboratory Inc. (TYO:9776)

Market Cap	6.09B +100.2%
Revenue (ttm)	20.39B +1.4%
Net Income	386.00M -11.5%
EPS	123.77 -9.7%
Shares Out	3.12M
PE Ratio	15.77
Forward PE	n/a
Dividend	23.00 (1.18%)
Ex-Dividend Date	Mar 28, 2025

Volume	4,700
Average Volume	9,545
Open	1,960.00
Previous Close	1,960.00
Day's Range	1,942.00 - 1,960.00
52-Week Range	888.00 - 2,074.00
Beta	0.35
RSI	48.91
Earnings Date	Feb 6, 2026

About TYO:9776

Sapporo Clinical Laboratory Inc. operates dispensing pharmacies in Japan. The company engages in contract and agency services for various clinical testing and public health testing, as well as food hygiene testing; sales and maintenance of software, such as clinical testing systems; management of dispensing pharmacies; and pharmaceutical wholesale. It also offers pathological examination, holter testing, radiation management, clinic opening support, test result inquiry services, and electronic medical record linkage. The company was incorporate...

• Industry: Medical - Diagnostics & Research
• Sector: Healthcare
• Founded: 1965
• Employees: 879
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 9776

Financial Performance

In fiscal year 2025, TYO:9776's revenue was 20.13 billion, an increase of 2.28% compared to the previous year's 19.68 billion. Earnings were 464.00 million, an increase of 22.11%.